معرفی
Dr. Rebecca Pellicano is a Senior Lecturer at the School of Clinical Sciences at Monash Health, Monash University, where she is actively engaged in clinical research and academic medicine. Her work spans nephrology, rheumatology, and medical education, with a focus on autoimmune diseases such as systemic lupus erythematosus and lupus nephritis.
Her research interests include:
- Clinical immunology and autoimmune diagnostics
- Lupus nephritis and biologic therapies
- Infection risk in immunocompromised patients
- Drug-induced kidney injury
- Medical student mental health and academic performance
Recent publications highlight her contributions to understanding anti-Ro antibodies in lupus, the use of belimumab in refractory cases, infection predictors, and adverse drug reactions. Her work often involves collaborative, multicenter studies and contributes to the UN Sustainable Development Goal of Good Health and Well-being.
Selected recent publications reflect trends in clinical rheumatology, nephrology, and medical education research, with increasing focus on patient outcomes, safety, and holistic care approaches.
Dr. Pellicano is the Primary Chief Investigator on the ongoing research project "Active CCRE in Renal Med (S/Ship)-Dr Pellicano," supported by Monash Health and the Department of Medicine. She has no listed scientific awards in the provided text.
She collaborates extensively with leading researchers including A. Hoi, A. R. Kitching, E. F. Morand, and V. Golder, contributing to team-based clinical investigations. She is also involved in research assessing psychological distress among medical students, indicating a dual commitment to clinical medicine and medical education improvement.
